发明授权
- 专利标题: Oxazolidinones useful as alpha 1a adrenoceptor antagonists
- 专利标题(中): 可用作α1a肾上腺素受体拮抗剂的恶唑烷酮
-
申请号: US09437841申请日: 1999-11-10
-
公开(公告)号: US06228870B1公开(公告)日: 2001-05-08
- 发明人: Jennie B. Nerenberg , Mark G. Bock , Michael A. Patane , Harold G. Selnick
- 申请人: Jennie B. Nerenberg , Mark G. Bock , Michael A. Patane , Harold G. Selnick
- 主分类号: A61K31445
- IPC分类号: A61K31445
摘要:
Novel hydroxymethyl- and alkoxymethyl-oxazolidinone compounds and pharmaceutically acceptable salts thereof are disclosed. The synthesis of these compounds and their use as alpha 1a adrenergic receptor antagonists is also described. One application of these compounds is in the treatment of benign prostatic hyperplasia. These compounds are selective in their ability to relax smooth muscle tissue enriched in the alpha 1a receptor subtype without at the same time inducing hypotension. One such tissue is found surrounding the urethral lining. Therefore, one utility of the instant compounds is to provide acute relief to males suffering from benign prostatic hyperplasia, by permitting less hindered urine flow. Another utility of the instant compounds is provided by combination with a human 5-alpha reductase inhibitory compound, such that both acute and chronic relief from the effects of benign prostatic hyperplasia can be achieved.
信息查询